已收盘 05-08 16:00:00 美东时间
-9.460
-1.99%
Wells Fargo analyst Brandon Couillard maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $675 to $615.
05-08 21:36
This whale alert can help traders discover the next big trading opportunities. ...
05-07 01:35
Banzai International, Inc. will implement a 1-for-20 reverse stock split of its Class A and Class B Common Stock effective May 8, 2026. The move aims to increase the per share price and maintain compliance with Nasdaq's minimum bid price requirement. After the split, every 20 shares will combine into 1 share, reducing the total outstanding shares from 23,587,400 to approximately 1,179,371. Fractional shares will be rounded up. The stock will cont...
05-06 12:00
Apple, Amazon and TSMC are among the largest companies to deliver earnings "triple plays" this season.
05-06 03:05
经济观察网 赛默飞世尔2026年一季度营收利润双增长,上调全年业绩指引,拟出售微生物业务 业绩经营情况: 公司2026年第一季度营收为110.05亿美元,同比增...
05-05 22:37
经济观察网 亨利香恩服务完成高管交接及董事会调整,2025年业绩表现亮眼,推进战略落地。 高管变动 2026年3月2日,公司完成了关键的管理层交接。执掌公司3...
05-03 03:58
华盛资讯5月1日讯,赛默飞世尔科技公布2026财年Q1业绩,公司Q1营收110.05亿美元,同比增长6.2%,归母净利润16.51亿美元,同比增长9.6%。
05-01 23:20
(来源:欧洲并购与投资) 赛默飞世尔出售微生物业务 图片来源于网络 近日,全球生命科学巨头赛默飞世尔科技(以下简称“赛默飞”)宣布,已签署协议将其微生...
04-29 07:31
赛默飞世尔达成协议,以约10.75 亿美元价格,将旗下微生物业务出售给欧洲私募机构阿斯特欧(Astorg) 赛默飞世尔表示,该微生物业务去年实现营收 ...
04-27 23:20
EKF Diagnostics publishes 2025 annual report EKF Diagnostics published its annual report for year ended Dec. 31, 2025, highlighting progress on five-year plan to simplify portfolio and exit non-core, lower-margin products. Point-of-care business increased analyzer placements, led by Hematology, aimi
04-27 15:59